The KEGG enrichment analysis indicates that the PI3K-AKT, T cell receptor, P53, and VEGF signaling pathways could potentially serve as crucial pathways for treating colorectal cancer with BZD, as illustrated in Figure 5D. This evidence concerns the gene VEGFA and colorectal cancer.